Table 4.
Functional and structural characteristics and number of injections in RPE discontinuity vs non-RPE discontinuity eyes
Mean (SD) | P-value | |
---|---|---|
VA at presentation | ||
No RPE discontinuity | 0.52 (0.27) | 0.11 |
RPE discontinuity | 0.64 (0.26) | |
VA in month 4 | ||
No RPE discontinuity | 0.41 (0.32) | 0.22 |
RPE discontinuity | 0.54 (0.48) | |
VA in month 6 | ||
No RPE discontinuity | 0.36 (0.22) | 0.027 |
RPE discontinuity | 0.61 (0.45) | |
CMT at presentation | ||
No RPE discontinuity | 345 (78) | 0.50 |
RPE discontinuity | 372 (135) | |
CMT in month 4 | ||
No RPE discontinuity | 300 (77) | 0.003 |
RPE discontinuity | 230 (51) | |
CMT in month 6 | ||
No RPE discontinuity | 295 (64) | 0.44 |
RPE discontinuity | 278 (82) | |
Number of injections | ||
No RPE discontinuity | 4.23 (0.92) | 0.007 |
RPE discontinuity | 3.55 (0.60) |
Abbreviations: RPE, retinal pigment epithelium; VA, visual acuity; CMT, central macular thickness; SD, standard deviation.